Does Smoking Weed Affect Bone Recovery?

Smoking weed does appear to impair bone recovery, based on a growing body of clinical and laboratory evidence. Cannabis users who sustain fractures tend to heal more slowly, face higher rates of nonunion (where the bone fails to knit back together), and in some surgical settings experience more complications than non-users. The picture is not as simple as “weed is bad for bones,” though, because the plant contains dozens of active compounds, and they do not all push in the same direction.

How Cannabis Talks to Your Skeleton

Your bones are not static structures. They are constantly being broken down and rebuilt by two types of cells: osteoclasts tear old bone apart, and osteoblasts lay down new bone. This process, called remodeling, is how fractures heal and how your skeleton stays strong over a lifetime. It turns out that bone cells have receptors specifically designed to respond to cannabinoids, the active chemicals in cannabis. Two receptors in particular, known as CB1 and CB2, are found throughout the skeleton and help regulate the balance between bone breakdown and bone formation.

The body makes its own cannabinoid-like molecules that bind to these receptors, and when you smoke weed, THC and other plant-derived cannabinoids flood the same system. Research in animals has shown that the endocannabinoid system influences both osteoclast and osteoblast activity, making it a genuine player in whether a broken bone heals well or poorly.¹ Bone cells also express a third receptor called GPR55, and studies in mice have found that blocking CB1, CB2, and GPR55 can suppress bone resorption and increase bone mass.² The takeaway is that cannabis is not just passively floating through your system when you smoke. It is actively interfering with the molecular machinery your body uses to rebuild bone.

Fractures Heal More Slowly in Cannabis Users

The most striking clinical data comes from studies tracking how long it takes broken bones to actually mend. A study of surgically treated fractures in adolescents found that marijuana users averaged about 159 days to achieve bone union, compared with roughly 80 days for non-users. Users were about four times more likely to still be unhealed at four months and six times more likely at six months.³ That is not a subtle difference. It means someone who smokes weed could be dealing with a fracture for twice as long as someone who does not.

Nonunion, where the bone simply never fuses, is another concern. Two large retrospective studies looked specifically at scaphoid fractures, a notoriously finicky bone in the wrist that is prone to healing problems even under ideal conditions. One review of nearly 160,000 patients found that cannabis-only users had a nonunion rate of about 10%, compared with roughly 8% for non-users, and that cannabis use independently predicted both nonunion and the need for subsequent surgery.⁴ A second analysis using different methodology confirmed the pattern: at two years, nonunion occurred in about 4.3% of cannabis-only users versus 2.0% of non-users, and people who used both cannabis and tobacco fared worst at 6.9%.⁵

These studies are observational, so they cannot prove that cannabis caused the healing failure. People who use cannabis heavily may also smoke tobacco, eat differently, or be less diligent about following their doctor’s instructions. But the association shows up consistently, and the combination of cannabis plus tobacco appears to compound the risk rather than simply adding to it.

Spinal Fusion Outcomes Tell a Complicated Story

Spinal fusion surgery offers another window into how cannabis affects bone healing, because the procedure relies on new bone growing to permanently join two vertebrae. A systematic review and meta-analysis found that cannabis users who underwent spinal fusion were roughly three and a half times more likely to need revision surgery compared with non-users.⁶ The reason for most of those revisions was pseudarthrosis, meaning the fusion never solidified. A separate multi-institutional study found that cannabis users were about 80% more likely to develop pseudarthrosis after a specific type of lumbar fusion, alongside significantly higher rates of both surgical and medical complications.⁷

Interestingly, not all spinal regions responded the same way. The meta-analysis found that the elevated revision rate was driven mainly by cervical (neck) fusions, where cannabis users had more than four times the revision rate. For lumbar (lower back) fusions alone, the difference between users and non-users was not statistically significant.⁶ And one earlier study of lumbar fusions specifically found no significant difference in complications or return-to-operating-room rates between cannabis users and non-users.⁸ Why cervical fusions appear more vulnerable remains unclear. One possibility is that the biomechanical demands differ between spine regions, and the margin for error is slimmer in the neck. Whatever the reason, if you are facing spinal fusion surgery, this is worth discussing with your surgeon.

THC and CBD Push Bone Cells in Opposite Directions

One of the most important nuances in this field is that cannabis is not a single substance. THC, the compound responsible for the high, and CBD, the non-intoxicating compound, appear to have very different effects on bone. Current evidence suggests that THC inhibits bone health and metabolism, while CBD may actually enhance it.⁹

In mouse studies, CBD and another non-psychoactive cannabinoid called CBG promoted bone formation and accelerated fracture repair. Treated mice showed stronger healed bones with better biomechanical properties, and the cannabinoids appeared to be both pain-relieving and pro-healing at the same time.¹⁰ Separately, lab work on CB2 receptor activation has found that stimulating this receptor can boost osteoblast numbers and activity while suppressing osteoclast formation, essentially tipping the balance toward more bone building and less bone breakdown.¹¹ Mouse studies using a CB2-targeting drug showed increased trabecular bone volume, driven by more active osteoblasts.¹²

This split matters because most recreational cannabis is bred for high THC content and relatively low CBD. When researchers talk about cannabis users having worse bone healing, they are generally studying people consuming THC-dominant products. The promising CBD findings come mostly from purified compounds administered in controlled animal experiments, not from someone hitting a joint. Whether CBD-rich products taken by a real person recovering from a fracture would reproduce those lab results remains an open question. A clinical trial protocol has been published to test exactly this: whether a one-month course of CBD after a long bone fracture reduces pain and inflammation while potentially aiding healing.¹³ Until results from trials like that arrive, the animal data is encouraging but unproven in humans.

The Smoking Part Matters on Its Own

When people ask whether smoking weed hurts bone recovery, the word “smoking” deserves its own spotlight. Inhaling combustion products, regardless of what is being burned, damages blood vessels and restricts blood flow. Fracture healing depends heavily on angiogenesis, the growth of new blood vessels into the injury site that deliver oxygen and nutrients to rebuilding bone cells. An animal study on cigarette smoke inhalation found that the smoking group had dramatically fewer microvessels around the fracture site after one week, roughly a quarter of what the control group showed. Even at four weeks, the smoking group had far less blood vessel formation and cartilage development.¹⁴

That study used cigarette smoke, but smoked cannabis produces many of the same combustion byproducts: carbon monoxide, tar, and particulate matter that irritate the airways and constrict blood vessels. Animal research using cannabis smoke specifically has shown that it impairs cancellous (spongy) bone healing.¹⁵ This creates a frustrating situation for researchers trying to isolate the pharmacological effects of THC from the vascular damage caused by smoke inhalation. When clinical studies report worse bone healing in cannabis users, it is hard to know how much blame belongs to THC itself versus the act of inhaling hot smoke. The clinical data on nonunion and delayed healing largely comes from populations where smoking is the dominant route. Whether vaping, edibles, or tinctures carry the same bone-healing risk is genuinely unknown, because no studies have cleanly separated delivery methods in fracture patients.

Lower Bone Density and Higher Fracture Risk

Beyond healing, cannabis use is also linked to weaker bones in the first place. A study comparing heavy cannabis users with non-users found that heavy users had significantly lower bone mineral density at both the hip and spine. At the spine, the effect accounted for roughly 5% of the variation in bone density, which is meaningful for a single lifestyle factor. However, mediation analysis revealed that the spine density effect was partly indirect, driven by the fact that heavy cannabis users tended to have lower body weight, and lighter people generally have less dense bones.¹⁶

At the hip, the association was more direct and independent of body weight. This matters because lower bone density means bones break more easily. If you are a heavy cannabis user, you may be starting from a weaker baseline before a fracture even happens, and then facing a slower recovery once it does. The combination of weaker starting material and impaired healing is a double disadvantage that most people are unaware of.

What About Dental Implants and Oral Bone

Bone recovery is not limited to fractures. Dental implants depend on a process called osseointegration, where the jawbone grows directly onto the surface of a titanium post. A rat study found that cannabis smoke inhalation significantly reduced bone-to-implant contact and bone area in the spongy bone surrounding implants, though cortical bone was not affected.¹⁷ In humans, a large retrospective analysis of over 50,000 dental implants found that marijuana use was significantly associated with implant failure in preliminary analysis.¹⁸

If you are planning to get dental implants, this is probably not the risk factor at the top of your mind. Most patients and many dentists think about diabetes, smoking cigarettes, and bone quantity. Cannabis use rarely comes up in the pre-implant conversation, but the evidence suggests it should.

Pain Management Creates Its Own Bone Problem

One reason people use cannabis after a fracture or surgery is pain relief. This creates an ironic feedback loop worth understanding. If cannabis delays bone healing, you hurt longer, meaning you may use more cannabis or more opioids, which delays healing further. Opioids themselves are not innocent bystanders here: they inhibit effective bone remodeling, increase the risk of pseudarthrosis, and can cause a paradoxical increase in pain sensitivity.¹³

Cannabis users who undergo orthopedic surgery also tend to use more opioids postoperatively than non-users.⁹ This may reflect tolerance to pain-modifying compounds, or it may be that cannabis simply does not manage surgical pain well enough on its own. A scoping review of cannabis and CBD for postoperative orthopedic pain found that CBD-only products showed mixed results, THC/CBD combinations had modest potential for reducing opioid needs, and the one THC-only study actually saw increased opioid use and longer hospital stays.¹⁹ The evidence is thin, but what exists does not paint a picture of cannabis as a reliable substitute for conventional pain management after bone injuries.

Age, Sex, and Strain All Change the Equation

The endocannabinoid system’s effect on bone is not identical across all people or even all mice. Research has found that strain, age, and sex all influence the skeletal outcome of cannabinoid receptor activation.²⁰ In one illustrative example, mice lacking the CB1 receptor had higher peak bone mass when young, because bone resorption was reduced. But those same mice developed pronounced osteoporosis as they aged, because CB1 also helps regulate the balance between osteoblasts and fat cells in the bone marrow. Without CB1, marrow stromal cells increasingly became fat cells instead of bone-building cells, and the mice lost bone rapidly.²¹

The lesson is that the cannabinoid system does different things at different life stages. Flooding it with THC at age 20 might produce a different skeletal effect than doing so at age 55, and the effect in men may differ from women. The clinical studies on fracture healing have mostly not been large enough or well-designed enough to tease out these subgroup differences in humans. For now, the honest answer is that we know cannabis use broadly associates with worse bone outcomes, but we do not yet know who is most vulnerable.

Biomaterials and the Future of Cannabinoid-Assisted Healing

While the evidence currently weighs against smoking weed during bone recovery, some researchers are trying to harness the helpful parts of the plant while discarding the harmful ones. Work is underway on biomaterials loaded with non-psychoactive cannabinoids like CBD and CBG, designed to be placed directly at a fracture or surgical site. These materials could deliver bone-promoting cannabinoids exactly where they are needed without the systemic effects of smoking or even oral consumption.²² Early in-vitro and animal studies show improved biocompatibility and promising bone regeneration, though human trials are still a long way off.

The field also stands to gain from drugs that target the CB2 receptor specifically. Unlike CB1, which is concentrated in the brain and drives the psychoactive effects of THC, CB2 is more active in bone and immune tissue. A CB2-targeting compound could theoretically boost bone formation and suppress bone resorption without getting you high. Lab studies have demonstrated exactly this effect in mice, where a CB2 agonist stimulated osteoblast activity and protected against bone loss after ovariectomy.¹¹ Blocking cannabinoid receptors entirely has also shown bone-protective properties, with CB1 and CB2 antagonists preventing ovariectomy-induced bone loss by promoting osteoclast cell death.²³ The paradox of both activating and blocking these receptors producing bone benefits reflects the complexity of the system; it depends on which receptor, at what dose, and in what context. None of these approaches are available as treatments today, but they represent a credible path toward using cannabinoid biology to help bones rather than hinder them.